Vergoeding 2020-2024 voor ATC-subgroep L04AF : Jak-remmers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L04AF01 Tofacitinib | 10.730.509 | 11.569.330 | 9.520.985 | 9.148.391 | 7.949.605 |
| L04AF02 Baricitinib | 8.141.555 | 10.332.475 | 10.451.069 | 9.295.453 | 8.183.583 |
| L04AF03 Upadacitinib | 303.547 | 2.860.013 | 7.916.575 | 10.719.182 | 15.423.179 |
| L04AF04 Filgotinib | 3.079 | 1.114.195 | 4.231.995 | 5.876.434 | 6.006.155 |
| L04AF07 Deucravacitinib | . | . | . | . | 9.866 |
| Totaal | 19.178.690 | 25.876.013 | 32.120.625 | 35.039.460 | 37.572.387 |